Physitrack PLC - Interim Report: January - September 2025

About this update from Physitrack Limited

LONDON, GB / ACCESS Newswire / October 21, 2025 / Physitrack PLC (STO:PTRK) - Fourth Consecutive Quarter of Resilient, Cash-Generative Growth, Marking Historical Positive Cash flow. Investor snapshot Summary for the period Third quarter: 1st July - 30th September 2025 Based on Alternative Key Performance Measures, the Company's key financial highlights for the period are summarised below. Performance broken down per division is provided later in this release. Summary for year to date September year to date: 1st January - 30th September 2025 Similarly, based on Alternative Key Performance Measures, the Company's key financial highlights for the nine months ended September 2025 are summarised below. Key highlights during the third quarter Q3 2025 marks a continuation of Physitrack's disciplined execution and financial resilience. Group pro forma revenue grew 6 per cent year-over-year to EUR 3.5m, supported by strong SaaS momentum in the Lifecare division and deliberate recalibration within Wellness. Constant-currency growth was 9 per cent year-over-year, underscoring the underlying strength of our subscription-led business model despite a seasonally flat quarter. High-Quality Earnings and Sustained Margin Strength Group pro forma adjusted EBITDA increased 25 per cent year-over-year to EUR 1.2m, growing adjusted EBITDA margin by 5 percentage points year on year to 33 per cent, demonstrating our ability to increase profitability through disciplined cost management and operating leverage. Adjusted EBITDA less CapEx increased nearly three-fold (297 per cent) year on year to EUR 0.4m, and free cash flow reached EUR 0.4m, marking the fourth consecutive quarter of positive cash generation, a reflection of our continued focus on sustainable, high-quality earnings. Subscription Revenue at Record Levels SaaS revenue accounted for 88 percent of total revenue in Q3, up six percentage points year-over-year and the highest in the company's history. Lifecare ARR rose 9 per cent year-over-year to EUR 11.7m, driven by recurring contract renewals and pricing optimisation. While Wellness ARR declined 20 per cent quarter-over-quarter following the prior quarter's strong rollout cycle and legacy contracts linked to the previous management team coming to an end. Operational Discipline Translating to Cash Flow Strength Free cash flow improved by EUR 0.8m versus Q3 2024, underpinned by a leaner cost base and greater capital efficiency. Our operational model continues to generate sufficient cash to self-fund innovation, validating the strategic restructuring undertaken in early 2025. Executing for Sustainable, Scalable Growth Q3 performance reinforces that Physitrack's transformation is delivering a leaner, more automated, and higher-margin SaaS organisation. With continued cash generation, strong subscription mix, and stable customer retention, we are well-positioned for renewed top-line acceleration as commercial expansion initiatives in Lifecare and Wellness ramp through 2026. CEO Interview A Physitrack Spotlight interview with CEO & co-founder Henrik Molin commenting on the report is available at: https://vimeo.com/1128286240/e67e23e024?fl=tl&fe=ec To create dynamism in the messaging, AI was used for key elements of the production, including the interviewer's appearance and voice. Lifecare Division Summary: Financial Performance (Quarterly & YTD View) SaaS KPIs (Quarterly) This includes Lifecare SaaS entities Physitrack and Physiotools. Commentary Wellness Division Summary: Financial Performance (Quarterly & YTD View) SaaS KPIs (Quarterly) This includes Wellness SaaS entity Champion Health. Commentary Webcast conference: October 21, 2025, at 15.00 CET. The presentation will be held in English and will be available on https://www.physitrackgroup.com after the webcast conference. Speakers: Henrik Molin, CEO Matt Poulter, Interim CFO Link to webcast registration: https://us06web.zoom.us/webinar/register/WN_EzpVLgJJRwmXTWVpB6hvkQ Participants will be able to ask questions via Zoom's Q&A function. Enquiries regarding this announcement should be addressed to: Henrik Molin, CEO and co-founder, Physitrack. +44 208 133 9325 [email protected] [email protected] About Physitrack Physitrack PLC, founded in 2012, is a global digital healthcare provider, focused on the B2B wellness and virtual-first care markets. With staff with 12 nationalities on four continents, customers in 17 time zones, and end users in 187 countries, Physitrack is a truly global company. The company has two business lines: 1. Lifecare - SaaS platform tailored mainly to physiotherapy and musculoskeletal care, enabling practitioners to deliver clinical home exercises, education prescription, outcomes tracking, triaging and Telehealth. 2. Wellness / Champion Health - SaaS platform for Employee Wellness and care powered by a combination of world-leading technology and wellness professionals based in the United Kingdom, Germany and the Nordics. Physitrack PLC is headquartered in London, United Kingdom, and listed on Nasdaq First North Premier Growth Market (PTRK). Visit us at https://physitrackgroup.com/ (investor relations) https://physitrack.com (product marketing) About Champion Health Champion Health, a subsidiary of Physitrack Plc, is a leader in corporate wellness technology, providing an innovative platform that empowers businesses to support their employees' well-being through personalised wellness action plans and advanced analytics. Visit us at https://championhealth.co.uk/ Attachments Q3 2025 Interim Report (FINAL) SOURCE: Physitrack PLC View the original press release on ACCESS Newswire

View stock analysis, news, and events for Physitrack Limited